Bispecific Antibodies as Novel Bioconjugates-Reference-Cited by-同舟云学术

Bispecific Antibodies as Novel Bioconjugates

Published:1998-10-20 Issue:6 Volume:9 Page:635-644
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Cao Y.¹,Suresh M. R.¹

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada, T6G 2N8

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc980044l

Reference119 articles.

1. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines

2. Anderson, P. M., Crist, W., Hasz, D., Carroll, A. J., Myers, D. E., and Uckun, F. M. (1992) G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells.Blood80, 2826−34.

3. Development of a bispecific monoclonal antibody for use in molecular hybridisation

4. Azuma, A., Yagita, H., Matsuda, H., Okumura, K., and Niitani, H. (1992) Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.Cancer Res.52, 4890−94.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Step Platform for Maduramicin and Salinomycin Detection Based on Bispecific Monoclonal Antibody and Interpretation of Molecular Recognition Mechanism;Journal of Agricultural and Food Chemistry;2023-11-15

2. Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry;JACS Au;2023-05-04

3. The ageing immune system as a potential target of senolytics;Oxford Open Immunology;2023-01-01

4. Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics;Antibodies;2021-03-30

5. Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds;Journal of Drug Targeting;2020-06-09